ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Ethics Commission Remains Split On Compensation But Tells To Develop Pilot Program Proposal

May 15, 1981

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

In Brief: Brown Named Dean At Wisconsin, Carnone To Head Cancer Center With Rusch Retirement

June 30, 1978

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

April 8, 1994

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980